Summary : The U.S. Food and Drug Administration has accepted Mirati Therapeutics’ New Drug Application (NDA) for its candidate drug for non-small cell lung cancer (NSCLC). The…
Approval
-
-
CompaniesCovid DrugsPfizer
Pfizer Postpones EUA in Kids Under 5, will Wait for Full Data
by adminby adminSummary – -On the day the public and members of the U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory…
-
436 RC meetingCIBRC - Indian Pesticide ApprovalsRC Meeting updates
INDIAN PESTICIDE APPROVAL UPDATES: 436th RC MEETING [CIBRC]
by adminby adminMINUTES OF THE 436th REGISTRATION COMMITTEE MEETING HELD ON 28.01.2022 The 436th meeting of the Registration Committee (RC) was held under the…
-
RegulatoryU.S FDA
FDA Investigating Possible Death Risk Linked to TG Therapeutics’ Lymphoma Drug
by adminby adminSynopsis: The U.S. Food and Drug Administration announced it is investigating a possible death risk for TG Therapeutics’ Ukoniq (umbralisib). The drug…
-
Today, the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine;…
-
Global MarketRegulatoryU.S FDA
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
by adminby adminSynopsis : The U.S. Food and Drug Administration, the National Institutes of Health, 10 pharmaceutical companies and five non-profit organizations have partnered…
-
AgrochemicalsGlobal Market
Delta Cargo approves the new Envirotainer Releye RLP container for fleet usage
by adminby adminSummary : Delta Cargo announced that it has approved the Envirotainer Releye RLP for usage on their fleet of aircraft. Envirotainer is…
-
CompaniesGlobal MarketNovartis
Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19
by adminby adminSynopsis : Novartis and Molecular Partners announced that Part A of the EMPATHY clinical trial(1) that compared single intravenous doses of ensovibep,…
-
Agrochemicals
Amgen and Arrakis Therapeutics announce multi-target collaboration to identify novel RNA degrader small molecule therapeutics
by adminby adminSynopsis : Amgen and Arrakis Therapeutics today announced a research collaboration focused on the discovery and development of RNA degrader therapeutics against…
-
Global MarketRegulatoryU.S FDA
Glenmark gets US FDA nod for Nasal Spray to treat seasonal Allergic Rhinitis
by adminby adminSynopsis : With this NDA approval, the company looks forward to bringing this new medicine to physicians and their patients for the…